Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Acetylcysteine

Base Information Edit
  • Chemical Name:Acetylcysteine
  • CAS No.:616-91-1
  • Deprecated CAS:7696-05-1,1261105-20-7,1261105-20-7
  • Molecular Formula:C5H9NO3S
  • Molecular Weight:163.197
  • Hs Code.:29309016
  • European Community (EC) Number:210-498-3
  • UNII:WYQ7N0BPYC
  • DSSTox Substance ID:DTXSID5020021
  • Nikkaji Number:J3.309J
  • Wikipedia:Acetylcysteine
  • Wikidata:Q375613
  • NCI Thesaurus Code:C200
  • RXCUI:197
  • Metabolomics Workbench ID:37912
  • ChEMBL ID:CHEMBL600
  • Mol file:616-91-1.mol
Acetylcysteine

Synonyms:Acétylcystéine GNR;acebraus;Acemuc;Acetabs;Acetylcystein AL;Acetylcystein Atid;Acetylcystein Heumann;Acetylcystein Trom;Acetylcystein, mentopin;Acetylcysteine;Acetylcysteine Hydrochloride;Acetylcysteine Sodium;Acetylcysteine Zinc;Acetylcysteine, (D)-Isomer;Acetylcysteine, (DL)-Isomer;Acetylcysteine, Monoammonium Salt;Acetylcysteine, Monosodium Salt;Acetylin;Acetyst;Acid, Mercapturic;Airbron;Alveolex;Azubronchin;Bisolvon NAC;Bromuc;Broncho Fips;Broncho-Fips;BronchoFips;Broncholysin;Broncoclar;Codotussyl;Cystamucil;Dampo Mucopect;durabronchal;Eurespiran;Exomuc;Fabrol;Fluimucil;Fluprowit;Frekatuss;Genac;Hoestil;Hustengetr?nk, Optipect;Hydrochloride, Acetylcysteine;Ilube;Jenacystein;Jenapharm;Lantamed;Larylin NAC;Lindocetyl;M Pectil;M-Pectil;mentopin Acetylcystein;Mercapturic Acid;Monoammonium Salt Acetylcysteine;Monosodium Salt Acetylcysteine;MPectil;Muciteran;Muco Sanigen;Mucomyst;Mucopect, Dampo;Mucosil;Mucosol;Mucosolvin;N Acetyl L cysteine;N Acetylcysteine;N-Acetyl-L-cysteine;N-Acetylcysteine;NAC AL;NAC Zambon;NAC, Bisolvon;Optipect Hustengetr?nk;Sanigen, Muco;Siccoral;Siran;Sodium, Acetylcysteine;Solmucol;Zambon, NAC;Zinc, Acetylcysteine

Suppliers and Price of Acetylcysteine
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • N-Acetyl-L-cysteine
  • 50g
  • $ 120.00
  • SynQuest Laboratories
  • N-Acetyl-L-cysteine
  • 500 g
  • $ 90.00
  • SynQuest Laboratories
  • N-Acetyl-L-cysteine
  • 25 g
  • $ 15.00
  • SynQuest Laboratories
  • N-Acetyl-L-cysteine
  • 100 g
  • $ 50.00
  • Sigma-Aldrich
  • N-Acetyl-L-cysteine Sigma Grade, ≥99% (TLC), powder
  • 500g
  • $ 576.00
  • Sigma-Aldrich
  • N-Acetyl-L-cysteine Sigma Grade, ≥99% (TLC), powder
  • 1kg
  • $ 747.00
  • Sigma-Aldrich
  • N-Acetyl-L-cysteine Sigma Grade, ≥99% (TLC), powder
  • 25g
  • $ 58.40
  • Sigma-Aldrich
  • N-Acetyl-L-cysteine Sigma Grade, ≥99% (TLC), powder
  • 10g
  • $ 34.10
  • Sigma-Aldrich
  • N-Acetyl-L-cysteine Sigma Grade, ≥99% (TLC), powder
  • 5g
  • $ 29.50
  • Sigma-Aldrich
  • N-Acetyl-L-cysteine cell culture tested, BioReagent
  • 5g
  • $ 29.20
Total 360 raw suppliers
Chemical Property of Acetylcysteine Edit
Chemical Property:
  • Appearance/Colour:White crystalline powder 
  • Vapor Pressure:8.68E-08mmHg at 25°C 
  • Melting Point:106-108 °C 
  • Refractive Index:24 ° (C=JPC Method) 
  • Boiling Point:407.678 °C at 760 mmHg 
  • PKA:pK1: 9.52 (30°C) 
  • Flash Point:200.357 °C 
  • PSA:105.20000 
  • Density:1.295 g/cm3 
  • LogP:-0.10360 
  • Storage Temp.:2-8°C 
  • Solubility.:H2O: 100 mg/mL with heating 
  • Water Solubility.:Soluble in water, ethanol, methanol, dimethyl sulfoxide, hot isopropyl alcohol, methyl acetate and ethyl acetate. Insoluble in c 
  • XLogP3:0.4
  • Hydrogen Bond Donor Count:3
  • Hydrogen Bond Acceptor Count:4
  • Rotatable Bond Count:3
  • Exact Mass:163.03031432
  • Heavy Atom Count:10
  • Complexity:148
Purity/Quality:

99% *data from raw suppliers

N-Acetyl-L-cysteine *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
  • Statements: 36/37/38 
  • Safety Statements: 22-24/25 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Drug Classes:Antidotes, Toxicological Emergency
  • Canonical SMILES:CC(=O)NC(CS)C(=O)O
  • Isomeric SMILES:CC(=O)N[C@@H](CS)C(=O)O
  • Recent ClinicalTrials:Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
  • Recent EU Clinical Trials:Efficacy and safety of the combination of acetylcysteine, paracetamol and phenylephrine for the treatment of common cold: a prospective, randomized, double-blind, controlled trial
  • Description N-Acetyl-L-cysteine is a kind of membrane penetrating antioxidant. It has anti-inflammatory activity through regulating the activation of NF-κB and HIF-1α as well as modulation of ROS. It can penetrate across the membrane, replenishes intracellular and glutathione and GSH to help the cell fight against oxidative stress. For these reasons, it has the potential for the treatment of neurodegeneration (such as Parkinson’s disease), radiation exposure and other disorders caused by oxidation. Moreover, it can also attenuate the allergic airway diseases.
  • Uses Paracetamol overdoseIntravenous N-Acetyl-L-cysteine?is indicated for the treatment of paracetamol (acetaminophen) overdose. When paracetamol is taken in large quantities, a minor metabolite called N-acetyl-p-benzoquinone imine (NAPQI) accumulates within the body. It is normally conjugated by glutathione, but when taken in excess, the body's glutathione reserves are not sufficient to inactivate the toxic NAPQI. This metabolite is then free to react with key hepatic enzymes, therefore damaging hepatocytes. This may lead to severe liver damage and even death by fulminant liver failure.For this indication, N-Acetyl-L-cysteine?acts to augment the glutathione reserves in the body and, together with glutathione, directly bind to toxic metabolites. These actions serve to protect hepatocytes in the liver from NAPQI toxicity.Mucolytic therapyInhaled N-Acetyl-L-cysteine?is indicated for mucolytic (""mucusdissolving"") therapy as an adjuvant in respiratory conditions with excessive and / or thick mucus production. Such conditions include emphysema, bronchitis, tuberculosis, bronchiectasis, amyloidosis, pneumonia, cystic fibrosis, chronic obstructive pulmonary disease, and pulmonary fibrosis. It is also used post-operatively, as a diagnostic aid, and in tracheotomy care. It may be considered ineffective in cystic fibrosis.For this indication, N-Acetyl-L-cysteine?acts to reduce mucus viscosity by splitting disulfide bonds linking proteins present in the mucus (mucoproteins).Nephroprotective agentOral N-Acetyl-L-cysteine?is used for the prevention of radiocontrastinduced nephropathy (a form of acute renal failure). Some studies show that prior administration of N-Acetyl-L-cysteine?markedly decreases radiocontrast nephropathy, whereas others appear to cast doubt on its efficacy.Treatment of cyclo phosphamide - induced hemorrhagic cystitisN-Acetyl-L-cysteine?has been used for cyclophosphamide-induced hemorrhagic cystitis, although mesna is generally preferred due to the ability of N-Acetyl-L-cysteine?to diminish the effectiveness of cyclophosphamide.Microbiological useN-Acetyl-L-cysteine?can be used in Petroff's method i.e. liquefaction and decontamination of sputum, in preparation for diagnosis of tuberculosis.Interstitial lung diseaseN-Acetyl-L-cysteine?is used in the treatment of interstitial lung disease to prevent disease progression.PsychiatryN-Acetyl-L-cysteine?has been shown to reduce the symptoms of both schizophrenia and bipolar disorder in two placebo controlled trials conducted at Melbourne University. It is thought to act via modulation of NMDA glutamate receptors or by increasing glutathione.Poly cystic ovary syndromeIn a small prospective trial comparing N-Acetyl-L-cysteine?to metformin (which is the standard drug treatment for PCOS), both treatments resulted in a significant decrease in body mass index, hirsutism score, fasting insulin, HOMA index, free testosterone and menstrual irregularity compared with baseline values, and both treatments had equal efficacy. A metabolite of Methyl Isocyanate.N-Acetyl-L-cysteine, by itself a poor scavenger of oxidants, is converted inside cells to yield sulfane sulfur species, which are very potent scavengers of oxidants. An antioxidant mucolytic acetylated amino acid. N-acetyl-l-cysteine (NAC) is a derivative of the dietary amino acid l-cysteine. NAC has a high affinity for lung tissue, which it supports through mucolytic and antioxidant action. NAC also enhances glutathione production and plays a role in heavy metal detoxification. n-acetyl-l-cysteine is a skin conditioner. It may also be used as an anti-aging ingredient given a demonstrated ability to regulate skin atrophy and reduce the appearance of fine lines and wrinkles.
  • Clinical Use Treatment of paracetamol overdose Renal protection during radiological scans involving contrast media (unlicensed) Treatment of mucolytic in respiratory disorders
  • Drug interactions Potentially hazardous interactions with other drugs None known
Technology Process of Acetylcysteine

There total 23 articles about Acetylcysteine which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With sodium acetate; In tetrahydrofuran; water; at 10 - 60 ℃; for 37h; pH=4 - 5; Inert atmosphere;
Guidance literature:
With lithium perchlorate; In methanol; (electrolysis);
DOI:10.1021/ja00769a087
Refernces Edit

Synthesis of natural product-inspired inhibitors of Mycobacterium tuberculosis mycothiol-associated enzymes: The first inhibitors of GlcNAc-Ins deacetylase

10.1021/jm070669h

The research focuses on the synthesis and evaluation of a chemical library of inhibitors targeting Mycobacterium tuberculosis mycothiol-associated enzymes, specifically GlcNAc-Ins deacetylase (MshB) and mycothiol-S-conjugate amidase (MCA). The purpose of this study was to develop small molecules that could interfere with mycothiol (MSH) biosynthesis or MSH-assisted detoxification, which could potentially serve as new antitubercular agents. The researchers synthesized a series of inhibitors based on natural product structures known to competitively inhibit MCA. The library of inhibitors was biased to include structural features of these natural products, and molecular docking studies were used to predict their binding modes within the active sites of the target enzymes. The study concluded that the synthesized inhibitors were the first reported to target MshB and supported the potential of natural product-substrate chimeras to act as dual inhibitors for both MshB and MCA. Key chemicals used in the synthesis process included 1-myo-D-inositol (myo-D-Ins), glucosamine (GlcN), N-acetyl-cysteine, and various sulfonyl chlorides, phosphonates, and other organic compounds to construct the desired inhibitor scaffolds and evaluate their biological activity.

Mechanistic analysis of an extracellular signal–Regulated kinase 2–Interacting compound that inhibits mutant BRAF-expressing melanoma cells by inducing oxidative stress

10.1124/jpet.120.000266

The research aims to investigate the mechanism by which a novel chemical compound, SF-3-030, selectively targets and inhibits the proliferation of melanoma cells with constitutively active ERK1/2 signaling, such as those harboring the BRAF V600E mutation. The study reveals that SF-3-030 interacts with ERK2, forming a covalent adduct on cysteine 252, which is near the docking site for substrate recruitment. This interaction leads to rapid changes in immediate early gene levels, particularly those containing the DEF motif, and induces an oxidative stress response, which is associated with the inhibition of melanoma cell proliferation. The research concludes that SF-3-030's mechanism of action is ROS-dependent but independent of NRF2, suggesting a potential therapeutic approach for melanoma treatment. Key chemicals used in the study include SF-3-030, ERK2, and various ROS inhibitors such as N-acetyl cysteine (NAC), sodium pyruvate, and mannitol.

Catalytic chain-breaking pyridinol antioxidants

10.1021/jo902226t

The study focuses on the synthesis and evaluation of 3-pyridinols, which are compounds carrying alkyltelluro, alkylseleno, and alkylthio groups, as potent antioxidant agents. These pyridinols were tested for their ability to inhibit azo-initiated peroxidation of linoleic acid in a water/chlorobenzene two-phase system and in a homogeneous phase. The chemicals used in the study include various 3-pyridinols with different substituents, N-acetylcysteine (NAC) as a water-soluble co-antioxidant, and N-tert-butoxycarbonyl cysteine methyl ester (LipCys), a lipid-soluble analogue of NAC. The purpose of these chemicals was to assess their antioxidant activity, specifically their capacity to quench peroxyl radicals, regenerate through reduction by thiol reducing agents, and their potential catalytic antioxidant behavior. The study aimed to understand the kinetic, thermodynamic, and mechanistic aspects of these antioxidants' activities and to identify the structural features that contribute to their high reactivity and effectiveness.

Post RFQ for Price